// App-Quantinova.ai

P504 : How acceptable is a ‘treat to target’ (T2T) approach to IBD patients in clinical remission?

Researchers

Presenter

  • J Carbonell

Principal Investigators

  • J Kane

  • M Omer

  • A Odouri Ochieng

  • M Pinder

  • R McKay

  • J Hamlin

  • C Selinger

Medical Centers

  • Leeds Teaching Hospitals NHS Trust, Gastroenterology, Leeds, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Depression

  • Anxiety

Biomarkers

  • C reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved